40 studies found for:    " February 03, 2010":" March 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 03, 2010":" March 05, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
Conditions: HIV-1 Infection;   HIV Infections
Intervention: Biological: PENNVAX-B
2 Active, not recruiting Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: DOT-HAART
3 Completed Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy
Conditions: HIV Infection;   Antiretroviral Side Effects;   Lipodystrophy Syndrome Related to HIV Infection
Intervention: Device: Eutrophill
4 Completed Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
Conditions: HIV;   HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
5 Completed A Safety Study of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo
6 Completed HIV Vaccine Study in HIV Positive Patients
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose);   Biological: HIV-v (High Dose);   Biological: HIV-v (Control)
7 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
8 Unknown  Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
9 Completed Cryptococcal Optimal ART Timing Trial
Conditions: Cryptococcal Meningitis;   HIV Infections;   AIDS
Interventions: Other: Early HIV Therapy Initiation;   Other: Active Comparer Standard HIV Therapy Initiation
10 Unknown  Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
11 Recruiting Stocrin Re-examination Study (0831-028)
Condition: HIV Infection
Intervention:
12 Completed A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
Condition: HIV Infection
Intervention: Drug: Minocycline
13 Completed Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Condition: HIV Infections
Interventions: Drug: darunavir/ritonavir QD + raltegravir BID;   Drug: darunavir/r QD + tenofovir/emtricitabine QD (fixed dose combination)
14 Completed Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: GSK1349572
15 Recruiting Alcohol Pharmacotherapy for HIV+ Prisoners
Conditions: Alcohol Dependence;   Problem Drinking;   Hazardous Drinking;   Human Immunodeficiency Virus;   AIDS
Interventions: Drug: Vivitrol- Intramuscular naltrexone (depot-formulation);   Drug: Placebo
16 Active, not recruiting Observational Data Analysis in EuroSIDA (0518-058)
Condition: HIV-1 Infections
Intervention:
17 Completed Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status
Conditions: Fracture;   Infection, Human Immunodeficiency Virus
Interventions: Other: No Antiretroviral (ARV) Drug Exposure;   Drug: Any Antiretroviral (ARV) Drug Exposure
18 Active, not recruiting Post-Licensure Safety Study of ISENTRESS™ in a US Managed Care Network (MK-0518-268)
Condition: HIV-1 Infections
Intervention:
19 Completed PENTA Fosamprenavir Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
20 Completed
Has Results
Evaluation of Kaletra Therapy Over the Long-term
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years